Maze Therapeutics Statistics
NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
31.37-1.06 (-3.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Maze Therapeutics by the numbers
Maze Therapeutics has a market capitalization of $1.72 billion based on 54.68M shares outstanding. With trailing EPS of $-2.62, Maze Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% above its 50-day average and 1.1% above its 200-day average.
Average daily trading volume is 737.14K shares, or about $23.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MAZE valuation vs. peer median
| Metric | MAZE | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.72B | $1.64B | +4% |
| Avg. volume | 737.14K | 1.79M | -59% |
Peer median across 8 companies: LYCA, REPL, COAG, BCRX, VIR, RXRX, ALVO, WWB.
Valuation
- Market cap
- $1.72B
- EPS (TTM)
- $-2.62
- Shares outstanding
- 54.68M
Price and trading
- Previous close
- 32.43
- Open
- 31.77
- Day range
- 30.88 – 32.80
- 52-week range
- 21.95 – 53.65
- 52-week change
- -13.49%
- Beta
- —
- Volume
- 818.93K
- Average volume
- 737.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 1.72B
- Forward Pe
- -9.51
- Eps
- -2.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 53.65
- Week52 Low
- 21.95
- Avg Volume
- 737.14K
- Shares Outstanding
- 54.68M
- Ma50
- 29.39
- Ma200
- 31.02
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -41.53%
- Pct From52w Low
- 42.92%